Eye on the Cure Podcast | Episode 90: Dr. Christina Ohnsman
Eye on the Cure
Dr. Christina Ohnsman talks about Tern Therapeutics, a start-up company she co-founded to develop gene therapies for Batten disease and potentially other conditions.
August 8, 2025. Dr. Christina Ohnsman talks to host Ben Shaberman about Tern Therapeutics, a start-up company she co-founded to develop gene therapies for Batten disease and potentially other conditions. Dr. Ohnsman reviews early results for a Batten disease (CLN2) retinal gene therapy clinical trial. She also reflects on her previous work as a pediatric ophthalmologist and roles with Spark Therapeutics and Regenxbio.
